Millipore Sigma Vibrant Logo

Press Releases

 
 

Current News


Whether it’s a new product enabling ground-breaking research, a strategic partnership with a customer, or a charitable partnership that supports our mission, we’ve always got something going on. Read our most recent press releases in the list below. Additionally, the search box allows you to filter by date or topic. 

表示
25.10.2021
「超純水製造装置 Milli-Q® Gradient」が「液体クロマトグラフィー科学遺産」に認定されました

当該製品が「液体クロマトグラフィー科学遺産」に認定されたことについてお知らせします。

20211025 超純水・純水製造装置
24.05.2021
SigmaAldrichサイトリニューアルに伴うパスワード再設定のお願い

このたび、サイトの利便性向上のため、sigmaaldrich.comがリニューアルを行いますのでお知らせします。

20210524 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
22.04.2021
ゴールデンウィーク 営業・出荷体制のご案内

2021 年ゴールデンウイークの営業・ご注⽂受付・出荷体制について、ご案内します

20210422 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
02.12.2020
年末年始の営業・出荷体制のご案内

年末年始の営業・出荷体制につきまして、ご案内します。

20201202 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
28.07.2020
夏季休業に伴う営業・出荷体制のご案内

夏季休業に伴う営業・出荷体制につきまして、ご案内いたします。

20200728 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
28.04.2020
GW休業に伴う営業・出荷体制のご案内

GW休業に伴う営業・出荷体制につきまして、ご案内いたします。

20200428 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
04.09.2019
消費税法改正に伴う対応のお知らせ

消費税法改正に伴う対応につきまして、ご案内いたします。

20190904 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
25.07.2019
夏季休業に伴う営業・出荷体制のご案内

夏季休業に伴う営業・出荷体制につきまして、ご案内いたします。

20190725 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
13.05.2019
分子生物学用・細胞培養用ボトル水製造終了のお知らせ

対象製品につきまして、製造終了と販売に関するご案内です。

20190513 超純水・純水製造装置
18.05.2018
製品ブランド、ラベル及びパッケージング変更に関するお知らせ

ライフサイエンスのすべてのブランド製品とパッケージングの変更のご案内です。

20180518 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
24.04.2018
メルク、ライフサイエンス業界で初めて研究者向けに LINEを活用したサービスを開始

身近なスマートフォンアプリを活用することで、ライフサイエンス分野の情報発信を強化。サイエンス系お役立ちメディア「M-hub」(エムハブ)も同時に開設

20180424 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,産業マイクロバイオロジー,低分子量医薬品,超純水・純水製造装置, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
29.01.2018
マルチプレックスアッセイ装置用消耗品 カタログ番号変更のお知らせ

対象製品につきまして、カタログ番号の変更をお知らせします。

20180129 ライフサイエンス研究
28.03.2018
MILLIPLEX® MAP製品に関するご案内

対象製品につきまして、販売中止をお知らせします。

20180328 ライフサイエンス研究
16.04.2018
102552:陰イオン界面活性剤セルテスト Webページ上の製品名誤記について

日本語web サイトにおける製品名の記載の誤記についてお知らせします。

20180416 化学分析とサンプル前処理
21.12.2017
スペクトロクァントNOVA 30&60 販売中止のご案内

対象製品につきまして、販売中止をお知らせします。

20171221 化学分析とサンプル前処理
04.12.2017
修理パーツ供給に関するご案内

対象製品につきまして、修理パーツ供給に関するご案内をいたします。

20171204 超純水・純水製造装置
16.10.2017
製品ブランドとパッケージング変更に関するお知らせ

対象製品につきまして、製品ブランドおよびパッケージング変更をお知らせします。

20171016 試薬、化学薬品、実験器具,産業マイクロバイオロジー, ライフサイエンス研究 ,化学分析とサンプル前処理
19.04.2017
メルク、ラボ用超純水製造装置「Milli-Q® IQ 7000」発売

メルクは、初めて環境に 優しい水銀フリーの UV ランプを採用したラボ用超純水製造装置「Milli-Q® IQ 7000」を2017年6月1日より発売いたします。

20170419 超純水・純水製造装置
22.05.2017
メルク、Grzybowski Scientific Inventions を買収、化学合成のサービスを拡大

メルクは5月9日、コンピュータを使った革新的な逆合成ツールである「Chematica」を開発した Grzybowski Scientific Inventions (グリズボウスキー サイエンティフィック インベンションズ)の買収を発表しました。

20170522
28.10.2016
メルク、新型高純水製造装置「Elix®」、サブセントラル純水製造・配水システム「Elix® + SDS500」を発売

メルク株式会社は、従来機種に比べ1.5倍の製造能力を備えた新型の高流量純水製造装置「Elix®(エリックス)」、効率的な純水運用を可能にするサブセントラル純水製造・配水システム「Elix® + SDS500」を2016年11月9日より発売いたします。

20161028 超純水・純水製造装置
28.10.2016
SmartFlare® RNA検出プローブ製造ライン見直しならびに販売継続製品のご案内

SmartFlare RNA検出プローブの製造ライン見直しと、販売継続製品についてご案内します。

20161028 ライフサイエンス研究
22.09.2016
Amicon(アミコン)攪拌式セル Model製品の販売中止のご案内

対象製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160922 ライフサイエンス研究
30.09.2016
MultiScreen® (マルチスクリーン) - PHフィルタープレートの販売中止のご案内

対象製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160930
20.09.2016
テトラフルオロホウ酸銀の製品規格変更のお知らせ

テトラフルオロホウ酸銀 合成用をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160920 試薬、化学薬品、実験器具,化学分析とサンプル前処理
20.09.2016
酸化ゲルマニウムの製品規格の変更のお知らせ

酸化ゲルマニウム (IV)製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160920 試薬、化学薬品、実験器具,化学分析とサンプル前処理
09.08.2016
ミリセル セルカルチャーインサートの原材料等変更のお知らせ

ミリセル セルカルチャーインサートをご購入のお客様へ変更内容をお知らせいたします。

20160809 ライフサイエンス研究
05.08.2016
塩化チタン(IV)合成用の製品規格変更のご案内

塩化チタン(IV)合成用をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160805 ライフサイエンス研究
05.08.2016
トルエン-4-スルホン酸・一水和物合成用の製品規格変更のご案内

トルエン-4-スルホン酸・一水和物合成用をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160805 ライフサイエンス研究
28.07.2016
アミコン製品に使用の限外ろ過膜製造施設移管のお知らせ

アミコン製品をご購入のお客様へ、対象製品の変更内容をお知らせいたします。

20160728 ライフサイエンス研究
25.07.2016
販売中止と代替品のご案内:SVGS0250S(カシベクスペディアトリックフィルター)

SLGV0250S(カシベクスGV)の発売にあたり、管理医療機器「SVGS0250S(カシベクスペディアトリックフィルター)」は、2017年3月31日(金)受注分をもって、販売中止とさせていただきます。

20160725 ライフサイエンス研究
02.06.2016
Histosec®60に関する変更のご案内

Histosec®60の試験成績書の使用期限日が誤って記載されていたことが判明しましたので、ご報告申し上げます。

20160602 ライフサイエンス研究
08.06.2016
Millex®シリンジフィルターに関する変更のご案内

Millexシリンジフィルターをご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160608 ライフサイエンス研究
23.05.2016
UDIシステム導入に関するご案内

弊社製品をご使用いただいておりますお客様へUDIシステム導入に関してお知らせいたします。

20160523 ライフサイエンス研究
23.05.2016
労働安全衛生法改正に伴う法規制ラベル表示変更のご案内

平成26年6月25日に公布されました労働安全衛生法改正に基づく製品、及び外装箱の法規制ラベル表示の変更をお知らせします。

20160523 ライフサイエンス研究
12.04.2016
Estapor®製品の製造工場移管のご案内

過去2年(国内は5年)以内にEstapor®対象製品をご購入のお客様へ変更内容をお知らせいたします。

20160412
08.04.2016
ゴールデンウィーク期間中の業務ご案内

弊社ではゴールデンウィーク期間中においては、暦どおり(祝・土日休業)営業いたします。

20160408
29.03.2016
'01型Milli-Q ・Elix UV・Direct-Q 修理パーツ製造終了予定のご案内

2001年~2009年に製造販売いたしました’01型Milli-Q ・Elix UV・Direct-Qの修理パーツを、2018年3月末にて製造終了させていただきます。

20160329 超純水・純水製造装置
22.03.2016
撹拌式セル製品の販売中止 のご案内

対象製品をご使用いただいているお客様へ変更内容をお知らせいたします。

20160322 ライフサイエンス研究
14.03.2016
Montage® 抗体精製キット販売中止 のご案内

Montage 抗体精製キットをご使用いただいているお客様へ販売中止をお知らせいたします。

20160314 ライフサイエンス研究
18.03.2016
ミリラップ(MilliWrap)販売中止 のご案内

ミリラップをご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160318 ライフサイエンス研究
01.03.2016
イモビロン(Immobilon)- P メンブレン等の製造施設移管のご案内

イモビロン(Immobilon)-Pメンブレン等をご使用いただいておりますお客様へ変更をお知らせいたします。

20160301 ライフサイエンス研究
16.02.2016
マイレクスMillex®-GPの品質証明書記載規格の変更のご案内

マイレクスMillex ®-GP製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160216 ライフサイエンス研究
08.02.2016
FGLP Fluoropore™ 疎水性 PTFE 0.2 μm メンブレン製品の原材料変更のお知らせ

Fluoropore™ 疎水性 PTFE 0.2 μm メンブレン製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20160208 ライフサイエンス研究
14.01.2016
マルチスクリーン (MultiScreen®)販売中止のご案内

マルチスクリーンをご使用していただいておりますお客様へ販売中止をお知らせいたします。

20160114 ライフサイエンス研究
14.01.2016
メルク、水質分析を容易かつ安全に行う高耐久性のシステム分光計測装置 「Spectroquant® Prove」シリーズを発表

廃水、飲用水、飲料、プロセス水(工業用水)の分析を容易かつ安全に行う高耐久性の新しい分光計測装置「Spectroquant® Prove(スペクトロクァント・プルーヴ)」を発表しました。

20160114 ライフサイエンス研究
17.12.2015
Millex®-GPおよびSteripakTM-GP製品の原材料等の変更のお知らせ

マイレクス-GPおよびステリパック -GP製品をご使用いただいておりますお客様へ変更内容をお知らせいたします。

20151217 ライフサイエンス研究
04.12.2015
製品名および規格等変更のお知らせ

撹拌式セルのオプションパーツである3製品につきまして、製品名および規格等の変更を行いますのでご案内いたします。

20151204 ライフサイエンス研究
25.11.2015
細胞培養用ウェルプレート製造終了のご案内

細胞培養用ウェルプレートを製造終了しますことをご案内いたします。

20151125 ライフサイエンス研究
07.12.2015
年末年始の業務体制について

年末年始の受注・出荷体制について、ご案内申し上げます。

20151207
01.12.2015
25mmフィルター0.2μmPTFE疎水性メンブレン原材料変更のお知らせ

25mmフィルター0.2μmPTFE疎水性メンブレンの変更内容をお知らせいたします。

20151201 ライフサイエンス研究
03.12.2015
親水性相互作用カラムZIC®-HILIC シリーズ カラム仕様の改良変更のご案内

両性イオン官能基型 親水性相互作用カラム ZIC-HILIC シリーズにつきまして、仕様変更がございます。

20151203 ライフサイエンス研究
17.11.2015
Centricon® Plus-70 ポリプロピレン樹脂の供給者変更のお知らせ

Centricon® Plus-70 Centrifugal Filtersの成形原料であるポリプロピレン樹脂の供給元を変更しました。

20151117 ライフサイエンス研究
24.09.2015
ミリセル(Millicell®) カルチャーインサート 8μm ポリカーボネート原料供給業者変更のご案内

ミリセル(Millicell®) カルチャーインサートに使用される8μm ポリカーボネート メンブレンのフィルム原料供給業者を変更いたしました。

20150924 ライフサイエンス研究
25.08.2015
シルバーウィーク期間中の営業・出荷体制のご案内

シルバーウィーク期間中の営業・出荷体制について、ご案内申し上げます。

20150825
05.08.2015
抗VEGF抗体(製品型番05-443)試薬用品に関するご注意

抗VEGF 抗体(製品型番05-443)ロットナンバー2488730の試薬用品についてのお知らせを致します。

20150805 ライフサイエンス研究
29.07.2015
夏季休業に伴う営業・出荷体制のご案内

弊社では、誠に勝手ながら8月12日(水)~8月14日(金)までを夏季休業期間とさせていただきます。

20150729
15.11.2015
実験器具用洗浄剤 Extran MAシリーズ 製造元変更のご案内(2015.11.15更新)

実験器具用洗浄剤エキストランMAシリーズの製造元が変更となります事をご案内申し上げます。

20151115 ライフサイエンス研究
08.06.2015
製品のお届けにお時間を頂戴する可能性があるAnimal Health Certificate必要製品リスト

アメリカ合衆国から輸入されている弊社製品のうち、輸入ための検査証明書の添付が必要と判断される製品は、USDA Certificateを添付しております。

20150608 ライフサイエンス研究
06.04.2015
Millicell®ハンギングセルカルチャーインサートに関する変更のお知らせ

Millicell®ハンギングセルカルチャーインサートの製造を、新しい施設に移管致しましたことをお知らせします。

20150406 ライフサイエンス研究
06.04.2015
Millex®4mm 非滅菌およびMillicup™製品に使用するFluoropore™ FGとFHメンブレンの原材料変更のお知らせ

Fluoropore™–FGおよびFHポリテトラフルオロエチレン(PTFE)メンブレンの製造に使用する原材料を、新しい供給業者の同等の原材料へと変更致しました。

20150406 ライフサイエンス研究
06.04.2015
メンブレンロールおよびカットディスク製品の製造場所変更のお知らせ

アメリカ マサチューセッツ州ベッドフォードにある弊社施設にて製造していたメンブレンロールおよびカットディスク製品が、アイルランド コークの弊社施設に移管致しました。

20150406 ライフサイエンス研究
06.04.2015
Millicell®およびMultiScreen®フィルタープレート/インサートの0.4μmポリカーボネートメンブレンに関する変更のお知らせ

Millicell®およびMultiScreen®フィルタープレート/インサート製品用のIsoporeTM0.4μmポリカーボネートメンブレン製造に使用するポリカーボネートフィルム材を、新たな供給業者から同等のポリカーボネートフィルムに変更致しました。

20150406 ライフサイエンス研究
06.04.2015
格子入メンブレンディスク製品に関するお知らせ

MF-Millipore™セルロース混合エステル(MCE)、Durapore®ポリフッ化ビニリデン(PVDF)およびFluoropore™とMitex™ポリテトラフルオロエチレン(PTFE)格子入メンブレンディスクについて最新鋭グリッディング工程設備投入を実施致しました。

20150406 ライフサイエンス研究
06.04.2015
セルロース混合エステル(MCE)メンブレン製品に関するお知らせ

対象製品のメンブレン製造に使用するニトロセルロース樹脂を、新しい供給業者の同等ニトロセルロース樹脂に変更致しましたこと。

20150406 ライフサイエンス研究
06.04.2015
Ultracel® 100K 再生セルロースメンブレンディスク製品に関するお知らせ

Ultracel® PL-100(100,000 MWCO)のメンブレンディスクの製造をアメリカ マサチューセッツ州ベッドフォードの弊社施設から、ニューハンプシャー ジャファリーの施設へ移管致しました。

20150406 ライフサイエンス研究
09.04.2015
メルクミリポア、高性能の純水製造装置「AFS® E システム」を発売

ライフサイエンス部門メルクミリポア事業本部は、 新型の高性能純水製造装置「AFS® Eシステム」を2015年4月より販売開始したことをお知らせいたします。

20150409 超純水・純水製造装置
01.04.2015
新製品 水道水直結型超純水装置Milli-Q® Integral MTシステム,製薬企業法令完全対応Milli-Q® Integral Pharmaシステム 発売のご案内

2015年4月1日より水道水直結型超純水装置Milli-Q Integral MTシステム及び Milli-Q Integral Pharmaシステムの発売を開始致します。

20150401 超純水・純水製造装置
18.02.2015
HepaRG™シリーズ製品販売中止のお知らせ

これまで弊社が製品販売を実施しておりましたHepaRG細胞および関連製品は、製品取扱を中止いたしました。

20150218 ライフサイエンス研究
07.01.2015
Millicell® 及びMultiScreen®フィルタープレート/ インサート製品0.4μmポリカーボネートメンブレンに関するお知らせ

Millicell®およびMultiScreen®フィルタープレート/インサート製品のIsopore™ 0.4μmポリカーボネートメンブレンの製造に使用するポリカーボネートフィルム材を変更致しました。

20150107 ライフサイエンス研究
07.01.2015
MF-Millipore™ セルロース混合エステル(MCE)0.45および0.8μmブラックメンブレンディスク製品に関するお知らせ

MF-Millipore™ MCE 0.45および0.8 μmブラックメンブレンディスク製品の製造に使用するニトロセルロース樹脂に変更致しました。

20150107 ライフサイエンス研究
07.01.2015
MF-Millipore™ セルロース混合エステル(MCE)メンブレン製品に関するお知らせ

MF-Millipore™ 0.8μmメンブレン製品の製造に使用するニトロセルロース樹脂を変更致しました。

20150107 ライフサイエンス研究
07.01.2015
Immobilon®-NC 0.45μm、MF-Millipore™ 0.22と0.45μm、および25mm Millex®0.22μmセルロース混合エステル(MCE)メンブレン製品に関するお知らせ

Immobilon®-NC 0.45μm、MF-Millipore™ 0.22と0.45μm、25mm Millex® 0.22μm MCE製品の製造に使用するニトロセルロース樹脂を変更致しました。

20150107 ライフサイエンス研究
25.12.2014
年末年始の業務体制について

年末年始の受注・出荷体制について、ご案内申し上げます。

20141225 試薬、化学薬品、実験器具,産業マイクロバイオロジー,低分子量医薬品,IVD/OEMキット、材質、試薬, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
17.11.2014
製品の使用期限誤記載に関するお知らせ(Guava Nexin Reagent 及び Muse Annexin V & Dead Cell Kit)

特定のGuava Nexin Reagent (100 および500Tests)、Muse Annexin V & Dead Cell Kit の製品ラベルの使用期限誤記載に関するお知らせです。

20141117 ライフサイエンス研究
31.10.2014
EDI® 方式小規模純水製造装置 AFS®-E ラボラトリーシステム カタログのご案内

2015年1月発売予定!高流量、高水質、イージーメンテナンスを実現しました。Elixグレードの純水を1日150L~800L採水可能なタンク内蔵型オールインワンユニットです。

20141031
22.10.2014
パーソナルユースSmartシリーズ 超純水製造装置 カタログ刊行(PDF)のご案内

Smartシリーズは、パーソナルユースの超純水装置です。少人数の方々でのご使用に最適な水量となっています。

20141022
01.10.2014
特定製品の原材料変更のご案内

過去2年以内に対象製品をご購入のお客様へ変更内容をお知らせいたします。

20141001 ライフサイエンス研究
06.10.2014
台風接近に伴う配達遅延のご案内

台風18号の接近により本日午前から夕方にかけ、首都圏に最接近する見通しとなっております。

20141006
10.09.2014
マイクロバイオロジーセミナー2014 - 製薬編 - 開催ご案内

2014年11月26日(水) 東京, 28日(金) 大阪 2会場にて開催いたします。 製薬企業様向けに無菌医薬品製造における迅速無菌試験に関する最新のトピックをテーマにて講演していただきます。

20140910
28.08.2014
Sterivex製品に関する各変更のご案内

過去2年以内に対象製品をご購入のお客様へ変更内容をお知らせいたします。

20140828 ライフサイエンス研究
28.08.2014
特定メンブレン製品の原材料・製品規格変更のご案内

過去2年以内に対象製品をご購入のお客様へ変更内容をお知らせいたします。

20140828 ライフサイエンス研究
02.09.2014
【キャンペーン】 Milli-Q40周年記念企画第一弾Milli-Q Integralキャンペーンが装い新たにスタート!

Milli-Q 40周年記念企画第一弾のMilli-Q Integralキャンペーンが、装い新たにスタートしました。事前登録の上、期間中にMilli-Q Integralをご購入で、Microsoft Surface 2やカタログギフトなど、ご希望の賞品が当たります!

20140902 超純水・純水製造装置
26.08.2014
メルクミリポア、バイオ医薬品製造の技術支援施設 「バイオマニュファクチャリングサイエンス・トレーニングセンター」開設

バイオ医薬品製造の技術支援施設「バイオマニュファクチャリングサイエンス・トレーニングセンター」を2014年9月4日に東京・お台場にオープンいたします。

20140826 バイオ医薬品製造
31.07.2014
特定メンブレン製品原材料変更のご案内

過去2年以内に対象製品をご購入のお客様へ変更内容をお知らせいたします。

20140731 ライフサイエンス研究
11.08.2014
レギュラトリーセミナー - 医薬品製造における添加剤に係わる品質・規制とリスクマネージメント -  開催ご案内

2014年9月4日(木) 東京・品川にて開催いたします。医薬品添加剤に係わる世界(日本、中国、インド、欧州)の規制動向ならびに将来を見据えたグローバル品質に対する現状や課題さらには今後の展望を講演していただきます。

20140811
28.07.2014
夏季休業に伴う営業・出荷体制のご案内

弊社では、誠に勝手ながら8月13日(水)~8月15日(金)までを夏季休業期間とさせていただきます。

20140728 試薬、化学薬品、実験器具,産業マイクロバイオロジー,低分子量医薬品,IVD/OEMキット、材質、試薬, ライフサイエンス研究 ,化学分析とサンプル前処理,バイオ医薬品製造
23.07.2014
Merck Millipore Bioforum 2014 - バイオ医薬品製造の先端技術と今後の展望- 開催ご案内

2014年9月4日(木) 東京・お台場にて開催いたします。今回は「バイオ医薬品製造の先端技術と今後の展望」と題し、この分野の専門家から 最新ソリューションや、将来の動向を見据えたバイオ医薬品製造の展望について 講演をいただきます。

20140723
01.03.2012
MultiScreen® HTS HV 384-well Platesに使用する樹脂変更のご案内

マルチスクリーンプレートで使用のスチレンアクリロニトリル(SAN)樹脂を、別の供給業者の同等SAN樹脂に変更したことをお知らせします。

20120301 ライフサイエンス研究
08.05.2012
弊社製品への毒物ラベル未貼付について

2012年4月10日、弊社取り扱い製品につきまして、毒物ラベルの貼付もれが判明致しました。

20120508 ライフサイエンス研究
18.05.2012
Linco-ELISAキット構成品の長期保存時の温度変更のお知らせ

弊社製品につきまして、長期保存時の温度について変更がございますのでご案内いたします。

20120518 ライフサイエンス研究
11.06.2012
Q-Pakカートリッジ販売再開のご案内

超純水装置Milli-Q SPシリーズならびにMilli-Q Plus用の消耗品について販売の再開をご案内申し上げます。

20120611
06.08.2012
PTFEメンブレン デバイス及びディスクの製造に使用される原材料の変更に関するご案内

PTFE (ポリテトラフルオロエチレン)メンブレンによるデバイスおよびディスクの製造に使用される原材料の変更をお知らせします。

20120806 ライフサイエンス研究
06.08.2012
Mitex™ PTFE メンブレンディスクの製造に使用される原材料の変更に関するご案内

Mitex™ PTFE (ポリテトラフルオロエチレン)メンブレンディスクの製造に使用される原材料の変更をお知らせします。

20120806 ライフサイエンス研究
06.08.2012
Millipore Express® PLUS ポリエーテルスルホン ディスクに使用されるメンブレンの原材料と工場の変更に関するご案内

Millipore Express PLUSメンブレン工場から、アイルランド コーク メンブレン工場への移管をお知らせ致します。

20120806 ライフサイエンス研究
30.08.2012
セルロース混合エステルメンブレン製品の製造に使用されるニトロセルロース樹脂の変更に関するご案内

特定のセルロース混合エステルメンブレン(MCE)製品に使用のニトロセルロース樹脂が代替予定であることをお知らせします。

20120830 ライフサイエンス研究
27.09.2012
ヒトES細胞用培地HEScGROおよび関連製品の製造中止に関するご案内

ヒトES細胞用培地HEScGROおよび関連製品が製造中止となりましたたことをご案内させていただきます。

20120927 ライフサイエンス研究
02.10.2012
Milli-Q SP TOC 有機物分解用UVランプ及びMilli-Q SP TOCポリッシャーカートリッジ販売再開のご案内

販売を終了させていただきました超純水装置Milli-Q SP TOC用の消耗品について販売の再開をご案内申し上げます。

20121002
02.10.2012
純水製造装置AQUELIX販売終了のご案内

純水製造装置AQUELIXですが、安定した品質での供給が困難になったことから、販売を終了させていただくことといたしました。

20121002
07.11.2012
幹細胞用培地製品に使用される原材料変更に関するご案内

一部の特定の幹細胞用培地製品が順次変更されることをお知らせします。

20121107 ライフサイエンス研究
08.11.2012
SNAP i.d. 2.0®の販売開始に伴うSNAP i.d. 及び消耗品の販売終了のお知らせ

SNAP i.d.(カタログ番号:WBAVDBASE)の販売を2012年12月末にて終了させていただく運びとなりました。

20121108 ライフサイエンス研究
10.01.2013
Ultracel® PLAC 1,000 NMWL限外ろ過ディスクの変更に関するご案内

Ultracel® PLAC 1,000 NMWL限外ろ過ディスクに使用されるメンブレンを変更したことをお知らせします。

20130110 ライフサイエンス研究
10.01.2013
PM30 限外ろ過ディスクの製造中止に関するご案内

PM30 30K ポリエーテルスルホン限外ろ過ディスクの製造中止と、代替品のUltracel® PLTK 30K 再生セルロース限外ろ過ディスクをお知らせします。

20130110 ライフサイエンス研究
10.01.2013
Millex® デバイス内に使用される Millipore Express® PLUS メンブレンの工場および原材料の変更に関するご案内

Millipore Express® PLUSメンブレンを今後製造する予定の、アイルランド コーク工場を拡張していることを知らせします。

20130110 ライフサイエンス研究
10.01.2013
Millipore Express® PLUSメンブレンの変更に関するご案内

GP Stericup®、Steritop®、Stericap™製品に使用されるMillipore Express® PLUSメンブレンの製造を、アイルランド コーク工場へ移管したことをお知らせします。

20130110 ライフサイエンス研究
22.01.2013
33 mm非滅菌マイレクス(Millex®)シリンジフィルター0.2 μmナイロンメンブレン装着タイプの流量変更に関するご案内

33 mm 非滅菌マイレクス(Millex®)シリンジフィルター 0.2 μm ナイロン(GN)メンブレン装着タイプの水流量を変更していることをお知らせします。

20130122 ライフサイエンス研究
26.01.2013
エアベントフィルター 型番: ZFRE012FC の販売終了予定案内および型番:TANKVNT02 の販売再開のご案内

エアベントフィルター 型番:TANKVNT02 につきまして製造を再開できることとなりましたのでご案内させていただきます。

20130126
30.01.2013
最適化済み細胞培養用培地製品の製造移管に関するご案内

リビングストン工場製の特定の細胞培養用培地製品の製造が、カリフォルニア州テメキュラサイトへ移管を開始しております。

20130130 ライフサイエンス研究
12.02.2013
GPTセレクション試薬(型番:TR-1001)の製造工程変更のご案内

GPTセレクション試薬(型番:TR-1001)の製造工程を2013年1月7日から変更していることをお知らせします。

20130212 ライフサイエンス研究
25.02.2013
弊社MSDSのWeb掲載のご案内

MSDSの発行を義務付けられている製品にMSDSを同梱しておりましたが、弊社ホームページに掲載することと致しました。

20130225 ライフサイエンス研究
11.03.2013
MultiScreen® PCR96 フィルタープレートに使用するメンブレン変更のお知らせ

MultiScreen® PCR96 クリーンナップフィルタープレートの製造に使用されるメンブレンを変更したことをお知らせします。

20130311 ライフサイエンス研究
19.06.2013
Milli-Qシリーズ,Elixシリーズのロゴデザイン,カラー変更のお知らせ

一部製品につきましては旧ミリポアロゴが使用されておりますことから、順次メルクミリポアデザイン変更を進めております。

20130619 超純水・純水製造装置
25.06.2013
医療用マイレクス型番及びJAN code変更のお知らせ

医療用マイレクスの一部製品につきまして、型番及びJAN codeを変更することをお知らせします。

20130625 ライフサイエンス研究
04.10.2013
Mitex PTFEメンブレン用PTFE樹脂製造工程変更に関するお知らせ

Mitex TM PTFE (ポリテトラフルオロエチレン)メンブレン用PTFE樹脂の製造処理工程を変更することをお知らせします。

20131004 ライフサイエンス研究
23.10.2013
Centrifree Ultrafiltrationデバイスのメンブレン変更のお知らせ

Centrifree®デバイスのUltracel® YM-T再生セルロースメンブレンをUltracel® PL再生セルロースメンブレンに変更致します。

20131023 ライフサイエンス研究
12.11.2013
Isopore 0.4μmポリカーボネートメンブレンの提供中止のお知らせ

0.4μmのIsopore ポリカーボネートメンブレンのフィルター原反の供給が中断し、バックオーダーになることをお知らせします。

20131112 ライフサイエンス研究
12.11.2013
CellASIC ONIXマイクロフルイディクバクテリアプレートの製造工程変更のお知らせ

CellASIC® ONIXマイクロフルイディックバクテリアプレートの製造に対する変更のお知らせです。

20131112 ライフサイエンス研究
24.12.2013
GP SteritopとStericap製品に使用するMillipore Express PLUSメンブレンの製造サイトおよび原材料変更のお知らせ

Millipore Express® PLUSメンブレンを、最新式の設備の整った製造プラントにて製造することにより、その生産量の拡大を行っております。

20131224 ライフサイエンス研究
02.12.2013
Steriflip-GPフィルターユニットに使用しているMillipore Express PLUSメンブレンの製造サイトおよび樹脂変更のお知らせ

Steriflip® -GPフィルターユニットに使用しているMillipore Express® PLUSポリエーテルスルホン(PES)メンブレンの製造工場を、移動することをお知らせします。

20131202 ライフサイエンス研究
16.06.2014
メルクミリポアWebサイト、リニューアルのお知らせ

メルクミリポアのWebサイトが、一元検索が可能なWebサイトに生まれ変わりました。

20140616
26.02.2014
サーモフィッシャーサイエンティフィック株式会社(旧:日本ダイオネクス株式会社) 溶離液ジェネレータシステム用超純水製造装置ICW-2000修理パーツ販売終了のご案内

ICW-2000は、販売数量が極端に減少したことでパーツの供給が困難となっております。このことから、修理パーツの販売終了予定のご案内をさせていただきます。

20140226
17.02.2014
4L溶媒ボトルの形状変更につきまして

日頃ご愛顧頂いておりますMerckKGaA社製有機溶媒製品につきまして、4Lサイズのボトル形状が下記の通り変更となります為、ご案内申し上げます。

20140217
12.02.2014
Guava EasyCyte Mini/PlusおよびGuava PCA/PCA-96シリーズの修理・消耗品パーツおよび保守点検サービス終了予定のご案内

Guava EasyCyte Mini/PlusおよびGuava PCA/PCA-96シリーズはすでに販売を終了しており、修理・消耗品パーツおよび保守点検のサービスプランを終了させていただきます。

20140212
24.04.2014
LabScale TFFご使用のお客様へ 電源アダプター交換のお願い

ご使用いただいております電源アダプターを、電気用品安全法を順守した電源アダプターへ交換させて頂く必要がございます。

20140424
23.04.2014
医療用マイレクス新型番及び新JAN code製品 受注開始済のお知らせ

昨年6月より医療用マイレクスの一部製品につきまして、新型番及び新JAN code製品への変更…

20140423 ライフサイエンス研究 ,試薬、化学薬品、実験器具
26.05.2021
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.

20210526
20.05.2021
Merck Improves Lab Productivity Through Faster and More Sustainable Nucleic Acid Purification

Merck introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits.

20210520
18.05.2021
Merck Announces VectorY as Winner of its Advance Biotech Grant

Merck today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.

20210518
04.05.2021
Merck Partners with Topco Scientific Co. to Increase Greener Manufacturing Materials Usage

Merck today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry.

20210504
31.03.2021
Merck Establishes Collaboration Laboratory with Universitas Indonesia to Advance Life Science Research

Merck today announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia.

20210331
17.03.2021
メルク、ワクチンと救命治療の製造に不可欠なシングルユース製品の欧州での生産拡張計画を加速

Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France.

20210317
16.03.2021
Merck Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power

As part of its ongoing commitment to renewable energy, Merck has signed a 12-year, off-site, virtual power purchase agreement with Enel Green Power for the construction of a future wind and storage project in Texas.

20210316
25.02.2021
Merck to Manufacture Next-Generation Biotherapeutics for Alteogen

Merck today announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through Merck BioReliance® End-to-End Solutions.

20210225
15.02.2021
Merck Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions

Merck today launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services.

20210215
04.02.2021
Merck Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World

Merck today announced seven expanded partnerships with leading nonprofit organizations across the world.

20210204
07.01.2021
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

Merck today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).

20210107
07.12.2020
メルク、米国のライフサイエンス・ビジネスの生産能力を拡張

Merck today announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA.

20201207
20.11.2020
Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named to The Boston Globe’s ‘Top Places to Work’ List

Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to Work 2020” list.

20201120
07.11.2020
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality

Merck and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics.

20201107
06.11.2020
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China

Merck today announced the signing of a Letter of Intent with Donghao Lansheng (Group) Co., Ltd.

20201106
10.11.2020
Merck’s Latest Technologies Earn Industry Recognition for Accelerating Bioprocessing 4.0

Merck today announced that its first-to-market Blazar™ platform from the BioReliance® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent.

20201110
29.10.2020
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test

Merck today announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.

20201029
19.10.2020
Merck Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer

Merck today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.

20201019
13.10.2020
Merck New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies

Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.

20201013
12.10.2020
Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA

Merck today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.

20201012
08.10.2020
Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant

Merck today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.

20201008
08.10.2020
Merck Supporting Innovation in China with D1Med Collaboration

Merck Merck, a leading science and technology company, is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process.

20201008
06.10.2020
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant

MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location.

20201006
15.09.2020
Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time

Merck today announced an expansion of its Singapore biosafety testing laboratory services.

20200915
09.09.2020
Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion

Merck today announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA.

20200909
03.09.2020
Merck Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research

Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.

20200903
30.07.2020
Merck’s DOZN™ Green Chemistry Tool Named Top Project of the Year by Environment + Energy Leader

Merck today announced that it won a Top Project of the Year award from Environment + Energy Leader for its DOZN™ system, a quantitative tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.

20200730
15.07.2020
Merck Invests € 18 Million in New Life Science Laboratory in Switzerland

Merck has announced plans to build a new, € 18 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business.

20200715
10.07.2020
Merck Opens its Largest M Lab™ Collaboration Center in Shanghai

Merck opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.

20200710
06.07.2020
Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant

Merck today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.

20200706
01.07.2020
New Report Identifies Paths to Pandemic Resilience

A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.

20200701
01.07.2020
Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition

Merck today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems.

20200701
10.06.2020
Merck and 10x Genomics Launch Powerful New Option for CRISPR Research

Merck and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments.

20200610
27.05.2020
Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

Merck and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19.

20200527
11.05.2020
Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

Merck today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.

20200511
30.04.2020
Merck Accelerates Readiness of Bioprocessing Facility of the Future

Merck today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation.

20200430
21.04.2020
Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity

Merck today announced a second Carlsbad, California, U.S.A.-based facility for its BioReliance® viral and gene therapy service offering.

20200421
14.04.2020
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.

20200414
07.04.2020
Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology

Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.

20200407
03.03.2020
Merck’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab

Merck today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.

20200303
18.02.2020
Merck to Manufacture Elypta’s Liquid Biopsy Kits

Merck today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.

20200218
11.02.2020
Merck’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D

Merck today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists.

20200211
10.01.2020
Merck and CSIR-IMTECH Open High-tech Skill Development Center

Merck today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies.

20200110
19.12.2019
Merck Licenses Foundational CRISPR Integration Technology to Promega

Merck today announced that it has signed a license agreement providing Promega Corp.

20191219
26.11.2019
Japan and Singapore Grant CRISPR Patents to Merck

Merck today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases.

20191126
18.11.2019
Merck Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation

Merck today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing.

20191118
18.11.2019
Merck Expands in Gillingham, UK, Boosts Distribution Capabilities

Merck today announced the completion of a £9 million expansion to its Gillingham distribution centre.

20191118
12.11.2019
Merck Licenses CRISPR Gene-Editing Technology to Evotec

Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property.

20191112
10.10.2019
Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

Merck today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

20191010
19.09.2019
Merck Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience

Merck has launched its official flagship store (merckls.1688.com) on Alibaba’s 1688.com.

20190919
19.08.2019
Merck Granted 20 CRISPR Patents Total Worldwide

Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

20190819
06.08.2019
Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

20190806
24.07.2019
Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

Merck today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

20190724
18.07.2019
Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.

20190718
20.06.2019
Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named ‘Best Places to Work’ by Boston Business Journal

MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019

20190620 超純水・純水製造装置,低分子量医薬品,試薬、化学薬品、実験器具, ライフサイエンス研究 ,産業マイクロバイオロジー,IVD/OEMキット、材質、試薬,バイオ医薬品製造,化学分析とサンプル前処理
20.06.2019
Merck Introduces Mobile Laboratory to Promote Protein Research

Merck today announced a national campus tour in China for the company’s first mobile protein research laboratory.

20190620
30.05.2019
Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain

Merck today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.).

20190530
29.05.2019
Merck Announces Winners of School Science Competition

Merck today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year.

20190529
27.05.2019
Merck Expands Cell Culture Media Production Facility in Irvine

Merck today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility.

20190527
22.05.2019
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

Merck today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland.

20190522
20.05.2019
Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Merck today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.

20190520
07.05.2019
Merck Announces Winner of First Retrosynthetic Reaction Prediction Contest

Merck today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest.

20190507
30.04.2019
Merck and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety

Merck today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).

20190430
24.04.2019
Merck Introduces New Greener Solvent, Cyrene™

Merck today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source.

20190424
04.04.2019
Merck Recognized with INTERPHEX Exhibitor Award for Best New Product

Merck today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next-generation bioprocessing. Merck’s Pellicon® Capsule with Ultracel® Membrane has been recognized for Best New Product.

20190404 バイオ医薬品製造
02.04.2019
Merck Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing

Merck today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing.

20190402 低分子量医薬品,バイオ医薬品製造
20.03.2019
Merck Opens First M Lab™ Collaboration Center in Europe

Merck today officially opened its new M Lab™ Collaboration Center in Molsheim, France.

20190320 低分子量医薬品,バイオ医薬品製造
18.03.2019
Merck’s Milli-Q® Connect Combines Deep Water Purification Expertise with Cloud-based Digital Technology

Merck today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems.

20190318 超純水・純水製造装置
19.03.2019
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Merck today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.

20190319 低分子量医薬品,バイオ医薬品製造
14.03.2019
Zhejiang University Joins Merck’s CRISPR Core Partnership Program

Merck today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China.

20190314
07.03.2019
MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab

MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour.

20190307 低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
04.03.2019
Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck today announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells.

20190304 低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
19.02.2019
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

Merck today announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck’s patent application directed to its proxy-CRISPR technology.

20190219 低分子量医薬品,バイオ医薬品製造
04.02.2019
Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease

Merck today announced the winners of its Advance Biotech Grant program in Europe.

20190204 ライフサイエンス研究
15.01.2019
Merck Wins Life Science Industry Award® for Best Use of Social Media

Merck today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award® for best use of social media.

20190115
19.12.2018
Merck Collaborates with Kuraray to Improve Drug Delivery

Merck today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.

20181219 ライフサイエンス研究
10.12.2018
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

Merck today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.

20181210 ライフサイエンス研究
27.11.2018
Merck Wins Two R&D 100 Awards for Innovation in 2018

Merck today announced that it has won two R&D 100 Awards.

20181127 低分子量医薬品,バイオ医薬品製造
19.11.2018
Merck Announces Winners of 2018 Life Science Awards

Merck recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.

20181119 ライフサイエンス研究
05.11.2018
Merck Launches BioContinuum™ Platform for Next-Generation Process Improvements

Merck today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.

20181105 低分子量医薬品,バイオ医薬品製造
18.10.2018
Merck Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation

Merck today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million.

20181018
12.10.2018
Merck Recognized with CPhI Awards for Innovative Products

Merck announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.

20181012 低分子量医薬品,バイオ医薬品製造
04.10.2018
Merck Opens M Lab™ Collaboration Center in São Paulo, Brazil

Merck today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region.

20181004 低分子量医薬品,バイオ医薬品製造
02.10.2018
Merck Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation

Merck recognized four graduate students for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium in Darmstadt, Germany, on September 27.

20181002
18.09.2018
Merck Makes Major Investment in New Singapore Laboratory

Merck today announced the opening of a new 3,800-square-meter laboratory in Singapore.

20180918
12.09.2018
Merck to Open China’s First Mobius® Single-use Manufacturing Facility in Wuxi

Merck today announced the establishment of its first Mobius® Single-use Manufacturing Facility in China.

20180912
04.09.2018
Merck Launches Next-Generation Process Technologies for Intensified Drug Production

Merck today launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.

20180904 低分子量医薬品,バイオ医薬品製造
15.08.2018
Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases.

20180815 低分子量医薬品,バイオ医薬品製造
26.07.2018
メルクとInnoCore Pharmaceuticals、新しいドラッグデリバリーテクノロジーによって患者のコンプライアンスを向上

メルクとInnoCore Pharmaceuticals(オランダ/フローニンゲン)は、InnoCoreが特許を持つSynBiosys生物分解性ポリマーのプラットフォームを提供するために、グローバルな協力協定を結びました。

20180726 ライフサイエンス研究
02.07.2018
Merck to Expand Operations in Gillingham, UK

Merck today announced plans to expand its Gillingham, UK distribution centre.

20180702
20.06.2018
Tongji University Joins Merck’s CRISPR Core Partnership Program

Merck today announced a new CRISPR core partnership with Tongji University in Shanghai.

20180620 低分子量医薬品,バイオ医薬品製造
19.06.2018
Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology

Merck today announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.

20180619 ライフサイエンス研究
12.06.2018
Merck Drives Thought Leadership in Ethical Gene Editing

Merck today announced that The American Journal of Bioethics has accepted a novel publication on ethical issues in genome editing to be printed in its July issue.

20180612 ライフサイエンス研究 ,低分子量医薬品,バイオ医薬品製造
06.06.2018
Merck Completes Third and Final Registration Phase under the European Chemicals Regulation REACH

Merck today announced that it has successfully submitted a total of more than 1,000 registration dossiers under the European chemicals regulation REACH by the end of the third and final registration deadline of May 31, 2018.

20180606
05.06.2018
Merck Brings Biotechs Closer to Drug Therapy Production and Commercialization

Merck today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center in Burlington, Massachusetts, U.S.A., providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers.

20180605 低分子量医薬品,バイオ医薬品製造
29.05.2018
Merck Announces Collaboration with Solvias for New Pyrogen Detection Kit

Merck today announced a collaboration with Solvias, a Swiss contract research and service provider, to offer the PyroMAT™ System, a new MAT kit for pyrogen detection.

20180529 ライフサイエンス研究
16.05.2018
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

Merck today announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome).

20180516 低分子量医薬品,バイオ医薬品製造
27.04.2018
Merck Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection

Merck today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection.

20180427 ライフサイエンス研究
23.04.2018
Merck Receives Patent for CRISPR Technology in China

Merck today announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.

20180423 低分子量医薬品,バイオ医薬品製造
18.04.2018
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 低分子量医薬品,バイオ医薬品製造
17.04.2018
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing

Merck today introduced three new products to support flexible manufacturing of biologics.

20180417
12.04.2018
Merck Helps Accelerate Global Access to Affordable Vaccines

Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 低分子量医薬品,バイオ医薬品製造
28.03.2018
Merck Named Best Bioprocessing Supplier in Asia

Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 低分子量医薬品,バイオ医薬品製造
05.03.2018
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 低分子量医薬品,バイオ医薬品製造
28.02.2018
Merck Furthers Scientists’ Research Through Expanded Seeding Labs Partnership

Merck today announced an expansion of its partnership with Seeding Labs to accelerate teaching and research for thousands of scientists in the developing world.

20180228 ライフサイエンス研究
27.02.2018
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

Merck today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 低分子量医薬品,バイオ医薬品製造
26.02.2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 低分子量医薬品,バイオ医薬品製造
22.02.2018
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre

Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 低分子量医薬品,バイオ医薬品製造
22.02.2018
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 低分子量医薬品,バイオ医薬品製造
22.02.2018
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi

Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 低分子量医薬品,バイオ医薬品製造
22.02.2018
Merck Strengthens Corporate Responsibility Efforts with Nine New Signature Partnerships

Merck today announced nine new or expanded partnerships with leading nonprofit organizations across the world through its Life Science business sector.

20180222
21.02.2018
Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia

Merck today announced an additional investment of €40 million to build a robust manufacturing and distribution platform in Asia over a span of two years.

20180221
20.02.2018
Merck Receives Two More Patents for CRISPR Technology

Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.

20180220 低分子量医薬品,バイオ医薬品製造
13.02.2018
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 低分子量医薬品,バイオ医薬品製造
01.02.2018
Merck KGaA, Darmstadt, Germany Certified as one of the Top Employers North America 2018

For the second year in a row, the North American businesses of Merck KGaA, Darmstadt, Germany, a leading science and technology company, have been certified for the company’s outstanding employee offerings by the independent Top Employers Institute.

20180201
20.12.2017
Merck Collaborates with iCON™ to Offer BioReliance® End-to-End Turnkey Modular MAb Manufacturing Platform

Merck today announced a collaboration with IPS-Integrated Project Services, LLC and G-CON Manufacturing, Inc. to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.

20171220 低分子量医薬品,バイオ医薬品製造
20.12.2017
Merck Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing

Merck today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, USA, for its use in potentially transformative gene therapies.

20171220
19.12.2017
Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology

Merck today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for Merck’s patent application covering the company’s CRISPR technology.

20171219 低分子量医薬品,バイオ医薬品製造
11.12.2017
Merck Signs Distribution Agreement with Avanti® Polar Lipids

Merck today announced that it has entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of the USA-based company’s research lipids portfolio outside of the United States.

20171211 低分子量医薬品,バイオ医薬品製造
17.11.2017
Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe

Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, EMD Serono and MilliporeSigma, have been named to The Boston Globe's annual "Top Places to Work" list for the second year in a row.

20171117
13.11.2017
Merck Introduces Stericup® Quick Release System for Improved Cell Culture Filtration

Merck today launched the new Stericup® Quick Release 500 ml vacuum filtration system.

20171113 ライフサイエンス研究
01.11.2017
Merck and Samsung BioLogics to Extend Strategic Alliance

Merck today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.

20171101 低分子量医薬品,バイオ医薬品製造
24.10.2017
Canadian Patent Office to Grant Merck's Patent Application for CRISPR Technology

Merck today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR technology.

20171024 低分子量医薬品,バイオ医薬品製造
23.10.2017
Merck Announces $10,000 Grand Prize Winners of 2017 Life Science Awards

Merck has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony.

20171023
19.10.2017
Merck Brings Customers Closer to Gene Therapy Product Commercialization

Merck today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection.

20171019 低分子量医薬品,バイオ医薬品製造
11.10.2017
MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration

MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.

20171011
10.10.2017
Merck Presents ‘Future Forum’ at Boston’s HUBweek 2017

Merck will host a panel discussion, “The Personalized Cell Therapy Challenge: A Race Against Time,” featuring leading cell and gene therapy experts from academia, hospitals and industry.

20171010
10.10.2017
Merck Hosts Leading Scientists at Life Science Symposium in Greater Boston

Merck will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.

20171010 低分子量医薬品,バイオ医薬品製造
27.09.2017
Merck Provides Update on EU’s Horizon 2020 Program to Improve Biopharmaceutical Downstream Processing

Merck today announced an update on its participation in Horizon 2020, the EU Framework Program for Research and Innovation, to improve biopharmaceutical downstream processing.

20170927 低分子量医薬品,バイオ医薬品製造
26.09.2017
New, First-of-its Kind Filters by Merck Provide Twice the Filtration Capacity using Fully Synthetic Materials

Merck today announced Millistak+® HC Pro, the first portfolio of high- capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.

20170926 低分子量医薬品,バイオ医薬品製造
22.09.2017
Merck Opens China’s First BioReliance® End-to-End Biodevelopment Center in Shanghai

Merck today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region.

20170922 低分子量医薬品,バイオ医薬品製造
20.09.2017
Merck Introduces Eshmuno® P Anti-A and Anti-B Chromatography Resins for Enhancement of Plasma-Derived Immunoglobulin

Merck today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.

20170920 低分子量医薬品,バイオ医薬品製造
13.09.2017
Merck Expands Celonic’s Upstream Capabilities with Mobius® Single-use Bioreactors

Merck today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of Merck’s Mobius® single-use bioreactors.

20170913 低分子量医薬品,バイオ医薬品製造
11.09.2017
Merck Announces $5,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation

Merck recognized four student chemists for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium.

20170911
28.08.2017
Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities

Merck today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography.

20170828 低分子量医薬品,バイオ医薬品製造
30.08.2017
Merck Opens its First Customer Food Safety Studio

Merck has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food to collaborate with Merck scientists.

20170830 化学分析とサンプル前処理
29.08.2017
Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy

Merck today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, to support the biotechnology start-up’s ability to speed its lead oncology antibody drug candidate to clinical use.

20170829 低分子量医薬品,バイオ医薬品製造
08.08.2017
Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases

Merck today announced that it has formed a strategic alliance with Baylor College of Medicine...

20170808 低分子量医薬品,バイオ医薬品製造
03.08.2017
European Patent Office to Grant Merck's Patent Application for CRISPR Technology

Merck today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells.

20170803 低分子量医薬品,バイオ医薬品製造
27.06.2017
Merck Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products

Merck today announced that it has prevailed against Analis S.A. in a lawsuit ordering the Belgium-based laboratory equipment distributor to cease advertising that compares RephiLe Bioscience Ltd.’s lab water products with the lab water products of Merck.

20170627 超純水・純水製造装置
26.06.2017
Merck adds Chemical Products to Reaxys’ Chemistry Database

Merck today announced a collaboration with Elsevier, the information analytics company specializing in science and health, to add its products into Reaxys, Elsevier’s chemistry database.

20170626 試薬、化学薬品、実験器具
15.06.2017
Merck Expands Distribution Agreement with Public Health England

Merck today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank of induced pluripotent Stem Cells (EBiSC).

20170615
14.06.2017
Merck Awarded its First CRISPR Patent by Australian Patent Office

Merck today announced that the Australian Patent Office has granted the company patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells.

20170614 ライフサイエンス研究
16.05.2017
Merck’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune

Merck today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.

20170516 ライフサイエンス研究
17.05.2017
Merck Develops Alternative CRISPR Genome Editing Method

Merck has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific.

20170517 低分子量医薬品,バイオ医薬品製造
15.05.2017
Merck Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes

Merck today took a significant step toward increasing manufacturing flexibility and enabling higher productivity with the launch of the EX-CELL® Advanced™ HD Perfusion Medium.

20170515 低分子量医薬品,バイオ医薬品製造
12.05.2017
Merck Opens New M Lab™ Collaboration Center in Bangalore

Merck today announced the expansion of its M Lab™ Collaboration Center in Bangalore, India.

20170512
12.05.2017
Merck Opens First Joint Bioprocess Scale-up Lab with Stelis Biopharma in India

Merck today announced the opening of its first joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.

20170512 低分子量医薬品,バイオ医薬品製造
09.05.2017
Merck Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering

Merck today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica.

20170509
01.05.2017
MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities

MilliporeSigma and Avid Bioservices, Inc., today announced that Avid will upgrade its Myford clinical and commercial manufacturing facility with multiple Mobius® 2000-liter single-use bioreactors from MilliporeSigma.

20170501 低分子量医薬品,バイオ医薬品製造
25.04.2017
MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts.

20170425
20.04.2017
Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius® Bioreactors

Merck has announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of MilliporeSigma’s Mobius® single-use bioreactors.

20170420 低分子量医薬品,バイオ医薬品製造
05.04.2017
MilliporeSigma Announces First Stops in National Curiosity Cube™ Tour

MilliporeSigma has announced nine stops for the first half of its national, year-long Curiosity Cube™ tour.

20170405
03.04.2017
Merck Introduces Next-Generation High-Sensitivity Protein Detection Platform

Merck today announced the launch of its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.

20170403 ライフサイエンス研究
21.03.2017
Merck Introduces Mobius® MyWay Portfolio for Customized Single-Use Assemblies

Merck today launched the Mobius® MyWay portfolio, a program that allows more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.

20170321 低分子量医薬品,バイオ医薬品製造
06.03.2017
Merck Advances Lab Water Purification Technology with Milli-Q® IQ 7000 System

Merck today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation.

20170306 超純水・純水製造装置
15.02.2017
Merck to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai

Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck’s Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.

20170215 低分子量医薬品,バイオ医薬品製造
08.02.2017
North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer

Merck KGaA, Darmstadt, Germany has announced that its North American businesses have been certified by the Top Employers Institute for exceptional employee offerings.

20170208
03.02.2017
Merck Wins Scotland’s Life Science Award for Excellence in Community Engagement

Merck has received the 2017 Scotland’s Life Science Award for outstanding achievements in community engagement.

20170203
23.01.2017
Merck Announces Emerging Biotech Grant Program Winners

Merck today announced the winners of its Emerging Biotech Grant Program in Europe.

20170123 低分子量医薬品,バイオ医薬品製造
12.01.2017
MilliporeSigma Kicks Off Year-Long ‘Curiosity Cube™’ Tour

Recognizing that tomorrow’s discoveries depend on the next generation of scientists, MilliporeSigma has kicked off a year-long “Curiosity Cube™” tour.

20170112
10.01.2017
Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe

Merck today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.

20170110 低分子量医薬品,バイオ医薬品製造
04.01.2017
Merck Acquires BioControl to Strengthen Position in Food Safety Testing

Merck today announced it has acquired BioControl Systems Inc., a global leader in food safety testing.

20170104 バイオ医薬品製造
18.01.2017
Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage

Merck has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds

20170118
13.01.2017
Merck Introduces New Calibration Kit for In Vitro Diagnostic Use

Merck today announced the introduction of its new testosterone calibrator kit for in vitro diagnostic (IVD) use.

20170113
17.01.2017
Merck Opens Production Facility Exclusively for Meglumine in Spain

Merck today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.

20170117 低分子量医薬品,バイオ医薬品製造
19.12.2016
MilliporeSigma Announces Winner of Life Science Award in Bioseparations

MilliporeSigma today announced that Ying Li, from The Pennsylvania State University, has won the company’s Life Science Award in Bioseparations.

20161219
16.12.2016
MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising

MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2016 Life Science Industry Award® for most memorable advertising.

20161216
05.12.2016
Merck to Provide Provantage® End-to-End Services to Acticor Biotech SAS

Merck today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.

20161205 低分子量医薬品,バイオ医薬品製造
02.12.2016
Merck Launches Parteck® MXP Excipient for Increased Solubility

Merck today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.

20161202 低分子量医薬品,バイオ医薬品製造
02.12.2016
Merck Introduces MILLIPLEX® High Sensitivity Panel for Faster, More Economical Cytokine Assays

Merck today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays.

20161202 ライフサイエンス研究
01.12.2016
Merck Expands Distribution Agreement with Roche

Merck today announced an expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in 2015.

20161201
30.11.2016
Merck Collaborates with Evotec for Faster Target Identification Solution

Merck today announced that it has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for Merck’s collection of genetic reagents such as CRISPR and shRNA libraries.

20161130
18.11.2016
MilliporeSigma named ‘Top Place to Work’ by The Boston Globe

MilliporeSigma today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.

20161118
15.11.2016
MilliporeSigma Wins US Search Award for ‘Best In-House’ Team

MilliporeSigma today announced that its digital acquisition marketing team won the 2016 US Search award for “Best In-House” team.

20161115
14.11.2016
Merck Launches Next-Generation Technology for Advanced Live Cell Imaging

Merck has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging.

20161114 ライフサイエンス研究
11.11.2016
Merck Wins R&D 100 Award for Top Invention

Merck received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries—the first of its kind CRISPR libraries.

20161111
13.10.2016
Merck Introduces First Certified Spiking Solution® of Heavy Labeled Thyroglobulin Protein

Merck today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin in SigMatrix®, a synthetic surrogate serum.

20161013 試薬、化学薬品、実験器具,IVD/OEMキット、材質、試薬,化学分析とサンプル前処理
06.10.2016
Merck Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea

Merck today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.

20161006 低分子量医薬品,バイオ医薬品製造
05.10.2016
メルクのウディット・バトラがCPhI Pharmaから「年間最高CEO」賞を受賞

メルクは本日、同社のライフサイエンス事業のCEOであるウディット・バトラがライフサイエンスのイノベーションを世界的に前進させるというコミットメントに対し、CPhI Pharmaから2016年の「年間最高CEO」に選ばれたことを発表しました。

20161005 低分子量医薬品,バイオ医薬品製造
26.09.2016
Merck Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal

Merck is launching the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.

20160926 低分子量医薬品,バイオ医薬品製造
19.09.2016
Merck’s New Steritest™ Symbio Pump Accessories Enable Faster, Safer Sterility Testing in Any Setting

Merck has introduced a set of Steritest™ Symbio Pump systems accessories that accelerate and streamline sterility testing workflows.

20160919 産業マイクロバイオロジー
14.09.2016
Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes

Merck has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines.

20160914
13.09.2016
Merck Lab Earns ISO Accreditation for Quality Control of Culture Media

Merck today announced that its microbiology quality control laboratory in Eppelheim, Germany is now accredited for the quality control of the ReadyPlate™ and ReadyTube™ culture media tested there.

20160913 産業マイクロバイオロジー
08.09.2016
Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines

Merck today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.

20160908 低分子量医薬品,バイオ医薬品製造
03.08.2016
Merck Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing

Merck today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world.

20160803 試薬、化学薬品、実験器具,化学分析とサンプル前処理
01.08.2016
Merck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound

Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.

20160801 低分子量医薬品,バイオ医薬品製造
19.07.2016
Merck Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts

Merck today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck.

20160719
18.07.2016
Merck Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name

Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.

20160718 低分子量医薬品,バイオ医薬品製造
13.07.2016
Merck Advances Water Purification Systems with New High-Throughput Line

Merck today introduced the Elix® High-Throughput water purification system, providing laboratories with a reliable water purification solution for daily water volumes of up to 9000 liters.

20160713 超純水・純水製造装置
12.07.2016
メルク、徐放性注射剤用ポリマーを加えることで添加剤製品群を拡大

メルクは添加剤製品群を拡大するため、PCAS S.A.(フランス・ロンジュモー)と契約を締結しました。

20160712 低分子量医薬品,バイオ医薬品製造
28.06.2016
Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products

Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.

20160628 低分子量医薬品,バイオ医薬品製造
28.06.2016
Merck to Develop Next-Generation Purification Processes with International Vaccine Institute

Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.

20160628 低分子量医薬品,バイオ医薬品製造
07.06.2016
Merck Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model

Merck today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.

20160607 低分子量医薬品,バイオ医薬品製造
11.05.2016
Merck Expands Popular Line of Guava® Flow Cytometers

Merck is expanding its popular line of Guava® flow cytometers to include a high-power modulated green laser.

20160511 ライフサイエンス研究
10.05.2016
Merck Showcases New Innovations at Analytica 2016

Merck will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.

20160510 超純水・純水製造装置,試薬、化学薬品、実験器具, ライフサイエンス研究 ,産業マイクロバイオロジー,IVD/OEMキット、材質、試薬,化学分析とサンプル前処理
09.05.2016
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers

Merck today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.

20160509 ライフサイエンス研究
04.05.2016
Merck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion

Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.

20160504 低分子量医薬品,バイオ医薬品製造
02.05.2016
Merck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry

Merck today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.

20160502 低分子量医薬品,バイオ医薬品製造
27.04.2016
New Merck Products Bring Ease of Use to Single-Use

Merck is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.

20160427 低分子量医薬品,バイオ医薬品製造
26.04.2016
Merck Introduces First Multi-use Disposable Sterile Connectors for Biopharma at INTERPHEX 2016

Merck today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.

20160426 低分子量医薬品,バイオ医薬品製造
19.04.2016
Merck Earns Accreditation for Quality Control of Culture Media

Merck has received accreditation for the quality control of dehydrated culture media tested at its Microbiology Quality Control Laboratory in Darmstadt.

20160419 産業マイクロバイオロジー
14.04.2016
Merck Supports Next Generation of Scientists at USA Science & Engineering Festival

Merck today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C.

20160414
29.03.2016
Merck’s CRISPR Epigenetic Activator Named to The Scientist’s Top 10 Innovation List

Merck today announced that The Scientist magazine has named the company’s CRISPR Epigenetic Activator one of its Top 10 Innovations of 2015.

20160329 ライフサイエンス研究
21.03.2016
Merck Introduces IsoBag™ for Faster and Easier Transfer of Contact and Settle Plates

Merck today introduced the IsoBag™ for faster, easier and more convenient transfer of contact and settle plates to production isolators.

20160321 産業マイクロバイオロジー
07.03.2016
Life Science Leader Merck Launches New Innovations at Pittcon 2016

Merck is launching a range of new products for separation and analysis at the Pittcon Conference and Expo 2016 in Atlanta, Georgia, March 6 – 10, the world’s largest conference for laboratory science.

20160307 超純水・純水製造装置,試薬、化学薬品、実験器具,産業マイクロバイオロジー,化学分析とサンプル前処理
07.03.2016
Merck Launches Global Science Education Program to Inspire Future Scientists

Merck today announced the launch of SPARK, a global skills-based volunteer program that provides community service opportunities for its network of nearly 19,000 life science employees, with a focus on science and education.

20160307
08.01.2016
Merck Donates to American Red Cross to Support Greater St. Louis Flood Victims

Merck today announced it has donated $10,000 to the American Red Cross of the Greater St. Louis Region in support of the organization’s flood relief efforts.

20160108
16.12.2015
Merck Honored by R&D Magazine for Innovation

Merck today announced it has received two prestigious R&D Magazine 100 awards – one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.

20151216 超純水・純水製造装置,低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
18.11.2015
メルク、Sigma-Aldrichの買収を完了

メルクは本日、Sigma-Aldrichを170億ドルで買収する手続きを完了したと発表しました。これによってメルクは、グローバルで1,300億ドルの市場規模を持つライフサイエンス業界におけるリーダー企業の一社として、ライフサイエンス分野における最も困難な問題の解決に向け取り組む体制が整ったことになります。

20151118
20.11.2015
Merck Intends to Launch Innovative System for Monitoring CD4 T lymphocytes and T cells throughout Africa

Merck today hosted a discussion with renowned researchers to discuss the intention to launch its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts throughout Africa.

20151120 ライフサイエンス研究
18.11.2015
Merck Launches Innovative System for Monitoring T cells in HIV patients in Nigeria

Merck today announced the launch of its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts in HIV affected patients in Nigeria.

20151118 ライフサイエンス研究
09.11.2015
Merck Launches Novel Cancer Stem Cell Identification Kit, Exclusively Licensed from Johns Hopkins University

Merck today introduced the new AldeRed™ ALDH Detection Kit for identifying and isolating cancer stem cells.

20151109 ライフサイエンス研究
26.10.2015
Merck Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations

Merck today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.

20151026 低分子量医薬品,バイオ医薬品製造
22.10.2015
Merck to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut Ilaç

Merck today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.

20151022 低分子量医薬品,バイオ医薬品製造
21.10.2015
Merck Introduces Millipore Express® PHF Hydrophilic Sterilizing-Grade Filters for Fast, Efficient and Economical Buffer Filtration

Merck today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.

20151021 低分子量医薬品,バイオ医薬品製造
28.09.2015
Merck Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive Summit

Merck today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.

20150928 超純水・純水製造装置,低分子量医薬品,試薬、化学薬品、実験器具, ライフサイエンス研究 ,産業マイクロバイオロジー,IVD/OEMキット、材質、試薬,バイオ医薬品製造,化学分析とサンプル前処理
14.09.2015
Merck Introduces Enhancements to its Emprove® Program of Pharmaceutical Raw Materials to Facilitate Risk Assessment

Merck today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.

20150914 低分子量医薬品,バイオ医薬品製造
12.08.2015
Merck Announces Charitable Contribution to Massachusetts Institute of Technology (MIT) for Development of Novel Ebola Diagnostic and Tracking Platform

Merck today announced it is providing the Massachusetts Institute of Technology (MIT) with a $50,000 charitable contribution to support the development of a novel diagnostic and tracking platform for Ebola.

20150812
27.07.2015
Merck Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH

Merck today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.

20150727 低分子量医薬品,バイオ医薬品製造
16.06.2015
Merck’s Additions to the MAS-100® Product Family of Microbial Air Samplers Deliver Improved Functionality for Pharmaceutical Manufacturers

Merck today announced three additions to its MAS-100® product family.

20150616 産業マイクロバイオロジー
15.06.2015
Merck Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use

Merck today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.

20150615 低分子量医薬品,バイオ医薬品製造
15.06.2015
Merck Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service

Merck today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.

20150615 低分子量医薬品,バイオ医薬品製造
02.06.2015
Merck Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production

Merck today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.

20150602 低分子量医薬品,バイオ医薬品製造
01.06.2015
Merck Congratulates Nancy Hopkins, Ph.D. of the Koch Institute for Integrative Cancer Research (MIT) as Recipient of 2015 Alice C. Evans Award

Merck today announced that Nancy Hopkins, Ph.D., Amgen, Inc. Professor of Biology (emerita), Biology Department and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), is the recipient of the 2015 Merck Alice C. Evans Award for Leadership in Clinical Microbiology.

20150601 産業マイクロバイオロジー
01.06.2015
Merck Launches Cellvento™ CHO Cell Culture Media Platform for Optimized Cell Growth and Productivity

Merck today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.

20150601 低分子量医薬品,バイオ医薬品製造
21.05.2015
Merck Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for Increased Capacity, Recovery and Concentration

Merck today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of Merck’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.

20150521 低分子量医薬品,バイオ医薬品製造
21.05.2015
Merck Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMC™) Technology

Merck and Singulex, the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced that they have entered into a definitive agreement under which Merck will control and manage the Singulex Life Science Research business.

20150521 ライフサイエンス研究
06.05.2015
Study Finds Merck’s Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for Permeation Studies

Merck announced publication of a study showing that its Strat-M® synthetic membrane predicts skin permeation of chemical compounds during in vitro transdermal diffusion studies as effectively as human or animal skin.

20150506 ライフサイエンス研究
23.04.2015
Merck Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs

Merck today introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA).

20150423 ライフサイエンス研究
02.02.2015
Merck Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services

Merck today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.

20150202 低分子量医薬品,バイオ医薬品製造
27.01.2015
Merck Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control

Merck today announced the introduction of its AFS® 40E / 80E / 120E and 150E water purification systems.

20150127 超純水・純水製造装置
19.11.2014
Merck Launches Kit for Analyzing NFкB Translocation by Imaging Flow Cytometry

Merck today introduced the Amnis® NFкB Translocation kit, which allows researchers to better study the nuclear translocation of NFкB, a transcription factor that plays a central role in regulating key mammalian cell processes, including proliferation, inflammation, immune and stress responses.

20141119 ライフサイエンス研究
21.10.2014
Merck Introduces PureFlex™ Plus Single-Use Process Container Film for High-Volume Biopharmaceutical Applications

Merck has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.

20141021 低分子量医薬品,バイオ医薬品製造
06.11.2014
Merck's guava easyCyte™ 12 Flow Cytometer Offers Improved Resolution Down to 0.2 μm

Merck offers new data demonstrating improved performance for its guava easyCyte™ 12 flow cytometer, a simple and powerful benchtop method for multicolor flow cytometry.

20141106 ライフサイエンス研究
03.11.2014
Merck’s New SNAP i.d.® 2.0 System for Immunohistochemistry Minimizes Slide Handling

Merck has introduced the SNAP i.d.® 2.0 Protein Detection System for Immunohistochemistry (IHC), which streamlines immunohistochemistry workflows and significantly decreases slide handling time.

20141103 ライフサイエンス研究
22.09.2014
Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

Merck today announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.

20140922
15.09.2014
Merck Recognized for Technologically Advanced Products by R&D Magazine

Merck announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.

20140915 低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
28.08.2014
Compact, Easy-to-Use Steritest™ Symbio Pumps from Merck Leverage Industry Leading Technology for Improved Sterility Testing

Merck has launched Steritest™ Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms.

20140828 産業マイクロバイオロジー
26.08.2014
Merck Expands Biomanufacturing Sciences and Training Center in Japan and Announces Opening of New Location in Tokyo

Merck today announced the opening of a new Biomanufacturing Sciences Training Center (BSTC) facility in Tokyo.

20140826 低分子量医薬品,バイオ医薬品製造
20.08.2014
Merck Announces Strategic Alliance on Biopharmaceutical Manufacturing with Samsung BioLogics

Merck announced today that Merck and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.

20140820 低分子量医薬品,バイオ医薬品製造
05.05.2014
Merck Millipore Expands Provantage® Upstream Bioproduction Services to the North American Market

Merck Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.

20140505 低分子量医薬品,バイオ医薬品製造
09.04.2014
Merck Millipore and VWR Extend Western European Distribution Agreement

The contract includes a range of Merck Millipore products and reagents for chemical and microbiological analysis

20140409 試薬、化学薬品、実験器具,産業マイクロバイオロジー,化学分析とサンプル前処理
17.03.2014
Merck Millipore Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation

This collaboration will use Merck Millipore’s flow cytometry technology as a platform to accelerate the creation of new, more powerful diagnostic tools for research in blood disorders.

20140317 ライフサイエンス研究
10.03.2014
Merck Millipore Receives Grant from Massachusetts Life Sciences Center to Collaborate with Promethera Biosciences

This is one of four grants given to Life Science companies in Massachusetts to fund international collaboration as part of MLSC’s International Collaborative Industrial Program.

20140310 ライフサイエンス研究
04.02.2014
Merck Millipore Introduces DRYPOUR™ Packaging System to Minimize Caking of Pharmaceutical Raw Materials

The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.

20140204 バイオ医薬品製造,低分子量医薬品
29.01.2014
Merck Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products

The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.

20140129 低分子量医薬品,バイオ医薬品製造
17.12.2013
メルクミリポアでは平成25年台風第30号の被害に対して災害救援を提供しています

メルクミリポアはフィリピンで平成25年台風第30号のために甚大な被害を被った方々に製品と援助金を寄付しています。

20131217 産業マイクロバイオロジー
23.10.2013
Merck Millipore Launches CpGenome Direct Prep Bisulfite Modification Kit for Simplified One-Step Conversion of Unmethylated Cytosines

By eliminating the need to isolate genomic DNA prior to performing bisulfite analysis, the kit provides a simple and reliable protocol for one-step bisulfite conversion.

20131023 ライフサイエンス研究
08.11.2013
Merck Millipore Wins R&D Magazine 100 Award for its Direct Detect® Protein Quantitation System

The Direct Detect® system was recognized as one of R&D Magazine’s 100 most innovative and technologically significant products to be introduced into the marketplace.

20131108 ライフサイエンス研究
07.11.2013
Merck Millipore Donates $10,000 to Environmental and Energy Study Institute in Recognition of Energy Month

The donation will specifically support EESI’s Transportation and Communities Program, which emphasizes energy efficiency and renewable energy across the transportation sector.

20131107
16.10.2013
Merck Millipore to be Global Distributor for SmartRNAplex MicroRNA Profiling Assay

MicroRNA detection with SmartRNAplex requires just three steps: hybridize, label, and report.

20131016 ライフサイエンス研究
22.10.2013
Merck Millipore Introduces Parteck® SLC, Silica-based Excipient for Enhanced Drug Solubility and Bioavailability

Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.

20131022 低分子量医薬品,バイオ医薬品製造
22.10.2013
Merck Millipore Introduces the First Online Original Manufacturer Tracking Tool

The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.

20131022 低分子量医薬品,バイオ医薬品製造
10.10.2013
Beijing Higher Court Rules in Favor of Merck Millipore in Patent Infringement Case

The Court determined that RephiLe’s accused products fall into the protection scope of Merck Millipore’s patent.

20131010
12.09.2013
Merck Millipore Receives Recertification of GMP Compliance for Biodevelopment Centre in Martillac, France

Merck Millipore today announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the competent authority of France.

20130912 低分子量医薬品,バイオ医薬品製造
26.09.2013
Merck Millipore Accepts Stevie Awards for Direct Detect® and Muse® Products at the 2013 American Business Awards

These awards were distributed by the American Business Awards, the premier business award program in the United States - finalists were announced in June.

20130926 ライフサイエンス研究
19.04.2012
Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is a novel way to bring information about new technologies right to the workplace.

20120419 超純水・純水製造装置
07.02.2012
Merck Millipore Introduces Elix® Essential 3, 5, 10, 15 Water Purification Systems

The new systems integrate patented Elix electrodeionization (EDI) technology along with several other complementary water purification techniques.

20120207 超純水・純水製造装置
25.01.2012
Merck Millipore Enhances Range of Direct-Q® 3, 5, 8 Water Purification Systems

First launched in 2005, the Direct-Q systems met with immediate and continuing success

20120125 超純水・純水製造装置
21.02.2012
Merck Millipore Introduces AFS® 10E and AFS® 15E Water Purification Systems

The Merck Millipore AFS 10E and AFS 15E water purification systems integrate patented Elix® electrodeionization (EDI) technology along with several other complementary water purification techniques

20120221 超純水・純水製造装置
19.06.2012
Merck Millipore Introduces AFS® 8D and AFS® 16D Degassed Water Purification Systems

The new systems are designed to provide cost-effective, low-maintenance solutions for clinical analyzers requiring degassed clinical laboratory reagent water (CLRW).

20120619 超純水・純水製造装置
25.05.2011
Merck Millipore Introduces Bottled Water with Certified Water Quality

Water for Cell Culture and Water for Molecular Biology are produced in an ISO® 9001 / cGMP environment. The bottled water is subject to strict quality control tests.

20110525 超純水・純水製造装置
08.03.2011
Merck Millipore Introduces All-in-One Water Purification System for High-Volume Clinical Analyzers

The Elix Gulfstream Clinical water purification system will provide up to 100 liters per hour and 2000 liters of clinical laboratory reagent water (CLRW) daily

20110308 超純水・純水製造装置
18.09.2013
Merck Millipore Donates $5,000 and School Supplies for Children in Need

Merck Millipore Teams Up with the Vince Wilfork Foundation to Donate Backpacks and School Supplies to Boston-Area Students

20130918
16.09.2013
Merck Millipore Named One of the Top Charitable Contributors by the Boston Business Journal

Merck Millipore Named One of the Top Charitable Contributors by the Boston Business Journal

20130916
17.09.2013
Merck Millipore Introduces Novel Clarisolve Depth Filters

Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams

20130917 低分子量医薬品,バイオ医薬品製造
10.09.2013
Merck Millipore Donates $30,000 to charity: water in Recognition of World Water Week

Merck Millipore today announced a $30,000 donation to charity: water in recognition of World Water Week.

20130910
12.07.2013
Merck Millipore Opens New R&D Center, Expanding Capabilities in Bioavailability Enhancement and Oral Dosage Formulation

The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges

20130712 低分子量医薬品,バイオ医薬品製造
06.06.2013
Merck Millipore Direct Detect® and Muse Products Named as Finalists in 2013 American Business Awards

The Muse Cell Analyzer provides greater accuracy and precision than manual hemocytometry or image-based automated analysis.

20130606 ライフサイエンス研究
20.05.2013
Vince Wilfork Visits Merck Millipore’s Jaffrey, NH Manufacturing Facility and Thanks Employees for Supporting the Vince Wilfork Foundation

Since 2011, Merck Millipore has supported the Vince Wilfork Foundation and its efforts to fund critical research at several leading diabetes institutions.

20130520
12.06.2013
Merck Millipore Launches PluriSTEM™ Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells

The proprietary formulation includes Activin-A, TGFβ1, and b-FGF to promote stem cell self-renewal and potent small molecule combinations to inhibit unwanted spontaneous differentiation.

20130612 ライフサイエンス研究
24.06.2013
Merck Millipore Launches Cellvento™ CHO-200 Chemically Defined Cell Culture Medium for Consistent High Performance in Fed-Batch Mode

Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.

20130624 バイオ医薬品製造
08.07.2013
Merck Millipore Awards Annual Scholarships

This year’s recipients are Emily Caron, daughter of Merck Millipore employee Roger Caron and Alexander Murphy, stepson of Merck Millipore employee Heather Sue Murphy.

20130708
10.07.2013
150 Cyclists from Merck Millipore and Merck Serono Participated in 150 Mile Ride for MS

As a leading supplier of tools and technologies that support research for many chronic diseases including MS, Merck Millipore is proud to support the National Multiple Scleroses Society.

20130710
15.03.2012
Merck Millipore Launches Mobius® CellReady 50 L Single-use Stirred Tank Bioreactor

This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.

20120315 低分子量医薬品,バイオ医薬品製造
27.02.2012
Merck Millipore Opens its First Lab Water Production Site in China Ming Che, a China-exclusive brand, is on the way

The opening of this lab water production facility marks another milestone for Merck Millipore in China, reflecting its long term commitment to the market.

20120227 超純水・純水製造装置
08.05.2013
Merck Millipore Leadership Recognized with Diabetes Champion Award by JDRF

Christina Shasserre was recognized for Merck Millipore’s support of JDRF, which includes serving as the chair sponsor of the annual “Walk to Cure Diabetes.”

20130508
10.05.2013
Merck Millipore Receives Chairman’s Award from Massachusetts Governor at Associated Industries of Massachusetts Luncheon

This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in international trade.

20130510
14.05.2013
Merck Millipore Introduces Magna ChIP® HiSens Chromatin Immunoprecipitation Kits

These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios, and ultra-sensitive detection.

20130514 ライフサイエンス研究
21.05.2013
Merck Millipore and PharmaCell to Develop Optimized Large-Scale Expansion and Harvesting of HepaRG® Cells Grown from Bioreactors

The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.

20130521 バイオ医薬品製造
25.06.2012
Vincent Donovan to Lead BioPharmaceutical Process Solutions at Merck Millipore

Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.

20120625 バイオ医薬品製造
04.06.2012
Merck Millipore Demonstrates Successful Scale-up of Human Stem Cells on Microcarriers in the Mobius® CellReady 3 L Single-use Bioreactor

This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.

20120604 低分子量医薬品,バイオ医薬品製造
16.05.2012
Dana Hubbard, Head of Patents for Merck Millipore, named to Boston’s Top Rated Lawyers

This list, created by LexisNexis Matindale-Hubbell, is a peer-reviewed rating of the leading local lawyers who have reached the highest levels of ethical standards and professional excellence.

20120516
01.05.2013
Andrew Bulpin to Assume Leadership of Process Solutions at Merck Millipore

He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.

20130501 低分子量医薬品,バイオ医薬品製造
12.02.2012
Merck Millipore Adds Millistak® µPod Filter to Line of Disposable Depth Filter Systems

With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.

20120212 低分子量医薬品,バイオ医薬品製造
27.02.2012
Merck Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies

Merck Millipore and Charles River will collaborate to integrate the TrueSpike technology into viral clearance services provided by Charles River.

20120227 低分子量医薬品,バイオ医薬品製造
01.03.2012
Merck Millipore Introduces CellPrime Recombinant Human Lysozyme for Increased Protein Recovery From E. coli Production Systems

The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.

20120301 バイオ医薬品製造
12.03.2012
Merck Millipore and the Centre for Commercialization of Regenerative Medicine Collaborate to Optimize Conditions for Large-scale Stem Cell Cultivation

This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.

20120312 低分子量医薬品,バイオ医薬品製造
07.08.2012
Merck Millipore Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement

CellPrime Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.

20120807 バイオ医薬品製造
20.06.2012
Merck Millipore Launches Provantage® Solutions at BIO 2012

Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.

20120620 低分子量医薬品,バイオ医薬品製造
10.04.2012
Third Annual “Merck Millipore Pharma Forum” to Address Latest Developments in Pharmaceutical Raw Materials Industry

Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT.

20120410 低分子量医薬品,バイオ医薬品製造
10.07.2012
Merck Millipore Introduces Unique Lab Water E-Solution: Millitrack® Compliance

This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs that follow GxP regulations.

20120710
20.09.2012
Merck Millipore Announces the Opening of its State-of-the-Art GMP Bioproduction Facility in Martillac, France

The site will serve users of Merck Millipore’s Provantage Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.

20120920 低分子量医薬品,バイオ医薬品製造
12.09.2012
Merck Millipore Named 53rd on the Boston Business Journal’s List of Top Charitable Contributors

“We are very proud to make the Boston Business Journal’s List of Top Charitable Contributors once again,” says Tara Duplaga, Manager of the Merck Millipore Giving Program.

20120912
30.08.2012
Merck Millipore Donates $10,000 to charity: water in Recognition of World Water Week

World Water Week, held this year from August 26 to September 1, provides a forum for conversation and best practices concerning the ongoing clean water crisis in our global community.

20120830
08.08.2012
Merck Millipore Extends its Innovative NovaSeptum® Sterile Sampling Offerings

This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.

20120808 低分子量医薬品,バイオ医薬品製造
06.08.2012
Merck Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Chromatography

The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.

20120806 低分子量医薬品,バイオ医薬品製造
22.08.2012
Merck KGaA Acquires Cell Culture Media Specialist Biochrom AG

The acquisition will strengthen Merck Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for manufacturers.

20120822 低分子量医薬品,バイオ医薬品製造
14.08.2012
Merck Millipore Launches PureGenome Kits and Reagents for Fast and Efficient Preparation of Next Generation Sequencing Libraries

PureGenome library preparation is a simple, two-step process followed by amplification using Merck Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.

20120814 試薬、化学薬品、実験器具, ライフサイエンス研究
05.07.2012
Merck Millipore Wins Prestigious R&D Magazine 100 Award

The Samplicity® Filtration system provides a higher throughput, ergonomic alternative to syringe-tip filters for the preparation of liquid chromatography samples.

20120705 化学分析とサンプル前処理, ライフサイエンス研究
14.05.2012
Merck Millipore Muse Cell Analyzer Wins Prestigious red dot Design Award

Red dot is one of the world’s largest and most prestigious design competitions from Germany, and is one of the most sought-after quality marks for design recognition globally.

20120514 ライフサイエンス研究
17.04.2012
Merck Millipore Launches Strat-M Synthetic Membrane Model for in vitro Transdermal Diffusion Studies

The synthetic membrane can be successfully used in place of human or animal skin to provide information about permeation characteristics of the compound through human skin.

20120417 ライフサイエンス研究
16.04.2012
Merck Millipore Receives 2012 REBRAND 100 Global Award

The goal of Merck Millipore’s rebrand initiative was to support strategic branding during the merger and to define the brand’s positioning, vision, and mission.

20120416
21.03.2012
Merck Millipore Announces Exclusive Supply and Marketing Agreement With Ventria Bioscience to Expand its CellPrime Line of Non-animal Origin Products

This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by Merck Millipore to its customers on a global basis.

20120321 低分子量医薬品,バイオ医薬品製造
19.09.2012
Merck Millipore and the Institute of Bioprocess Engineering and Pharmaceutical Technology to Develop Optimized Process Control and Harvesting of Stem Cells Grown from Bioreactors

This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.

20120919 低分子量医薬品,バイオ医薬品製造
18.10.2012
Merck Millipore’s Process Solutions Business Unit Announces Updated 2013 Pricing For Pharm Chemical Solutions and Biopharm Process Solutions Products

The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.

20121018 低分子量医薬品,バイオ医薬品製造
09.10.2012
Merck Millipore Offers a Comprehensive and Growing Portfolio of Products and Technologies for Bioavailability Enhancement

This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.

20121009 低分子量医薬品,バイオ医薬品製造
12.10.2012
Merck Millipore Provides Grant to The Breast Cancer Research Foundation

The fund will be in the form of two grants of $250,000 each over a two-year period, and is the latest development in Merck Millipore’s two-year alliance with BCRF.

20121012
05.09.2012
Merck Millipore Introduces Cellvento CHO-100, a Chemically-defined, Non-animal Origin Media for Superior Cell Growth and Productivity

The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.

20120905 バイオ医薬品製造
18.09.2012
Merck Millipore and VeriStem Technologies to Develop Purification Methods for Large-scale Stem Cell Production

Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.

20120918 低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
17.09.2012
Merck Millipore Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ)

Under the agreement, Merck Millipore will continue to offer its STEMCCA™ reprogramming kits, which provide a highly efficient, reproducible method for creating iPS cells.

20120917 ライフサイエンス研究
07.01.2013
Merck Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Tangential Flow Filtration

Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.

20130107 低分子量医薬品,バイオ医薬品製造
15.11.2012
Merck Millipore Launches Eshmuno® CPX, a Strong Cation Exchanger Optimized for High Resolution and High Productivity

Built on Merck Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.

20121115 バイオ医薬品製造
13.11.2012
Merck Millipore Hosts Two Chromatography User Group Meetings

User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.

20121113 低分子量医薬品,バイオ医薬品製造
01.11.2012
Merck Millipore and Sistemic Collaborate to Identify Control Markers for Stem Cell Production

The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.

20121101 低分子量医薬品, ライフサイエンス研究 ,バイオ医薬品製造
30.04.2013
Merck Millipore Launches OsteoMAX-XF, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium

Mineralization can be detected in less than one week, whereas competing products that contain serum require approximately 21 days to produce similar levels of bone formation.

20130430 ライフサイエンス研究
23.04.2013
New SIRTainty Class III HDAC Assay from Merck Millipore Used in Recent Study Demonstrating Novel Mechanism for Activation of SIRT1

Unlike conventional assays that are dependent upon a single pre-labeled fluorescently tagged substrate, the SIRTainty Class III HDAC Assay employs untagged acetylated peptide substrates.

20130423 ライフサイエンス研究
28.02.2013
Merck Millipore Muse Cell Analyzer Wins Prestigious GOOD DESIGN® Award

The Chicago Athenaeum: Museum of Architecture and Design and Metropolitan Arts Press Ltd. present the Museum's annual GOOD DESIGN® Awards Program.

20130228 ライフサイエンス研究
02.05.2013
Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.

Merck Millipore announced the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.

20130502 低分子量医薬品,バイオ医薬品製造
29.01.2013
Expansion of EZ-Product Family for Faster, More Efficient Bioburden Analysis and Microbial Detection in Beverages

The EZ-product family now includes the EZ-Fluo rapid detection system, a non-destructive, fluorescent staining-based system for microbial detection.

20130129 産業マイクロバイオロジー
14.05.2013
Magna ChIP® HiSens Chromatin Immunoprecipitation Kits

These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios.

20130514 ライフサイエンス研究
31.03.2012
Direct Detect Biomolecular Quantitation System

A system for rapid, simplified protein quantitation exploits Merck Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains.

20120331 ライフサイエンス研究